{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:23Z","timestamp":1791314363090,"version":"4.3.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["P51RR165"],"award-info":[{"award-number":["P51RR165"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OD010930"],"award-info":[{"award-number":["OD010930"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS064991"],"award-info":[{"award-number":["NS064991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH100670"],"award-info":[{"award-number":["MH100670"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS084163"],"award-info":[{"award-number":["NS084163"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.drudis.2014.02.012","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T19:46:18Z","timestamp":1394826378000},"page":"980-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cell-based therapies for Huntington's disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Yiju","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In K.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W.S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2014.02.012_bib0005","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.drudis.2014.02.012_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/35039051","article-title":"Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease","volume":"1","author":"Gusella","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2014.02.012_bib0015","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.02.012_bib0020","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.drudis.2014.02.012_bib0025","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1093\/nar\/gks907","article-title":"Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway","volume":"40","author":"Hu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drudis.2014.02.012_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.drudis.2012.01.006","article-title":"Allele-selective inhibition of trinucleotide repeat genes","volume":"17","author":"Matsui","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2014.02.012_bib0035","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.02.012_bib0040","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.02.012_bib0045","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.02.012_bib0050","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0055","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.neuron.2012.06.001","article-title":"\u2018Huntingtin holiday\u2019: progress toward an antisense therapy for Huntington's disease","volume":"74","author":"Lu","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2014.02.012_bib0060","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI45130","article-title":"Oligonucleotide therapeutic approaches for Huntington disease","volume":"121","author":"Sah","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2014.02.012_bib0065","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1242\/dev.125.8.1529","article-title":"Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues","volume":"125","author":"Dragatsis","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.drudis.2014.02.012_bib0070","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.drudis.2014.02.012_bib0075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0085","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.drudis.2014.02.012_bib0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.expneurol.2011.11.020","article-title":"Widespread suppression of huntingtin with convection-enhanced delivery of siRNA","volume":"233","author":"Stiles","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0095","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/gt.2011.170","article-title":"Using non-coding small RNAs to develop therapies for Huntington's disease","volume":"18","author":"Zhang","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2014.02.012_bib0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/gt.2012.78","article-title":"Efficient gene expression from integration-deficient lentiviral vectors in the spinal cord","volume":"20","author":"Peluffo","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2014.02.012_bib0105","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/hep.24230","article-title":"Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk","volume":"53","author":"Matrai","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.drudis.2014.02.012_bib0110","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1038\/mtna.2013.27","article-title":"Fetal brain-directed AAV gene therapy results in rapid, robust, and persistent transduction of mouse choroid plexus epithelia","volume":"2","author":"Haddad","year":"2013","journal-title":"Mo. Ther. Nucleic Acids"},{"key":"10.1016\/j.drudis.2014.02.012_bib0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm0698-727","article-title":"Functional integration of striatal allografts in a primate model of Huntington's disease","volume":"4","author":"Kendall","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2014.02.012_bib0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(83)90150-4","article-title":"Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants","volume":"93","author":"Deckel","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0125","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3727\/096368912X657918","article-title":"Brain repair in a unilateral rat model of Huntington's disease: new insights into impairments and restoration of forelimb movement patterns","volume":"22","author":"Klein","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.drudis.2014.02.012_bib0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-Levi","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0135","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jnnp-2012-302441","article-title":"The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease","volume":"84","author":"Barker","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.drudis.2014.02.012_bib0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/aws359","article-title":"Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability","volume":"136","author":"Cisbani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2014.02.012_bib0145","article-title":"Single cell suspension methodology favours survival and vascularization of fetal striatal grafts in the YAC128 mouse model of Huntington's disease","author":"Cisbani","year":"2013","journal-title":"Cell Transplant."},{"key":"10.1016\/j.drudis.2014.02.012_bib0150","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ana.21788","article-title":"Slowed progression in models of Huntington disease by adipose stem cell transplantation","volume":"66","author":"Lee","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.stem.2012.01.021","article-title":"Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice","volume":"10","author":"Ma","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.drudis.2014.02.012_bib0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1242\/dev.084608","article-title":"Developmentally coordinated extrinsic signals drive human pluripotent stem cell differentiation toward authentic DARPP-321 medium-sized spiny neurons","volume":"140","author":"Carri","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.drudis.2014.02.012_bib0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2202-13-97","article-title":"Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6\/2 transgenic mouse model of Huntington's disease","volume":"13","author":"El-Akabawy","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.drudis.2014.02.012_bib0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-008-0465-0","article-title":"A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions","volume":"117","author":"Keene","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0175","doi-asserted-by":"crossref","first-page":"16707","DOI":"10.1073\/pnas.0808488105","article-title":"Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats","volume":"105","author":"Aubry","year":"2008","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.02.012_bib0180","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/nm1495","article-title":"Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes","volume":"12","author":"Roy","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2014.02.012_bib0185","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1073\/pnas.1221840110","article-title":"Long-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene","volume":"110","author":"McCracken","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.02.012_bib0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.rmr.0000180612.64338.41","article-title":"Future directions in body magnetic resonance imaging","volume":"16","author":"Hyslop","year":"2005","journal-title":"Top. Magn. Reson. Imaging"},{"key":"10.1016\/j.drudis.2014.02.012_bib0195","first-page":"6838","article-title":"In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors","volume":"63","author":"Kircher","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2014.02.012_bib0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/74464","article-title":"Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells","volume":"18","author":"Lewin","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/mrm.1910220209","article-title":"Target-specific superparamagnetic MR contrast agents","volume":"22","author":"Weissleder","year":"1991","journal-title":"Magn. Reson. Med"},{"key":"10.1016\/j.drudis.2014.02.012_bib0210","first-page":"411","article-title":"MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis","volume":"17","author":"Remsen","year":"1996","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0215","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0167-4889(98)00002-0","article-title":"Measuring transferrin receptor gene expression by NMR imaging","volume":"1402","author":"Moore","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2014.02.012_bib0220","doi-asserted-by":"crossref","first-page":"15256","DOI":"10.1073\/pnas.96.26.15256","article-title":"Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination","volume":"96","author":"Bulte","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2014.02.012_bib0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/mrm.10406","article-title":"MR molecular imaging of the Her-2\/neu receptor in breast cancer cells using targeted iron oxide nanoparticles","volume":"49","author":"Artemov","year":"2003","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.drudis.2014.02.012_bib0230","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/nbt1201-1141","article-title":"Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells","volume":"19","author":"Bulte","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2014.02.012_bib0235","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/mrm.21606","article-title":"MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter","volume":"59","author":"Zurkiya","year":"2008","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.drudis.2014.02.012_bib0240","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/gt.2011.2","article-title":"Evaluation of the specificity and sensitivity of ferritin as an MRI reporter gene in the mouse brain using lentiviral and adeno-associated viral vectors","volume":"18","author":"Vande Velde","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.drudis.2014.02.012_bib0245","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuroimage.2012.04.040","article-title":"Quantitative evaluation of MRI-based tracking of ferritin-labeled endogenous neural stem cell progeny in rodent brain","volume":"62","author":"Vande Velde","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.drudis.2014.02.012_bib0250","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2006.03.006","article-title":"Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration","volume":"1140","author":"Kaur","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2014.02.012_bib0255","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2009.08.043","article-title":"Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease","volume":"1297","author":"Kaur","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.drudis.2014.02.012_bib0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.jbchem.a124884","article-title":"Iron-regulated expression and membrane localization of the maga protein in Magnetospirillum sp, strain Amb-1","volume":"118","author":"Nakamura","year":"1995","journal-title":"J. Biochem."},{"key":"10.1016\/j.drudis.2014.02.012_bib0265","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/mrm.24509","article-title":"Divalent metal transporter, DMT1: a novel MRI reporter protein","volume":"70","author":"Bartelle","year":"2012","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.drudis.2014.02.012_bib0270","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington's disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2014.02.012_bib0275","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","article-title":"Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease","volume":"17","author":"Wang","year":"2008","journal-title":"Hum. Mol. Genet."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644614000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644614000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:17:13Z","timestamp":1761221833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644614000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1359644614000749"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2014.02.012","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-based therapies for Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2014.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}